Orient EuroPharma

OEP distributes and markets pharmaceutical products from international companies, including brands for cardiovascular, neurology, obstetrics & gynecology, oncology, and respiratory care. It also offers nutrition and baby care products under its own brand, developed with New Zealand’s Dairy Goat Co-operatives.

Home,OEP

ElendiLabs tracks China’s out-licensing of rare disease therapies, including a deal for a novel gene-editing treatment. The U.S. Section 232 investigation into pharmaceutical imports from China intensifies, with potential tariffs on key active pharmaceutical ingredients (APIs). The EU’s updated Pharma Package introduces stricter supply chain transparency rules for rare and orphan drugs, affecting global manufacturers.

Oct 2026ElendiLabsNews article

Rakuten Medical and Orient EuroPharma have entered an exclusive licensing agreement. The partnership grants Orient EuroPharma rights to distribute Rakuten Medical’s products in specific markets. Terms of the agreement include exclusive commercialization for select regions, expanding both companies’ market reach.

Jul 2025AbiesNews article

Rakuten Medical and Orient EuroPharma’s affiliate Cyntec secure an exclusive deal to co-develop and commercialize photoimmunotherapy products using Rakuten Medical’s **Alluminox™ platform** in **Taiwan, Malaysia, Singapore, and the Philippines**. The agreement grants Orient EuroPharma rights to distribute and advance these therapies in the specified Southeast Asian markets. Both companies will collaborate on bringing the platform’s proprietary technology to clinical and commercial use in the region.

Jun 2025Rakuten MedicalNews article

Rakuten Medical partners with Orient Europharma to develop and expand light-based cancer treatment solutions. The collaboration focuses on leveraging Orient Europharma’s pharmaceutical expertise alongside Rakuten Medical’s technology. Both companies aim to advance therapeutic approaches in oncology through this joint effort.

Jun 2025Nikkei AsiaNews article